Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(33 sites)

United States

Urology Centers of Alabama, Homewood, Alabama

Arkansas Urology, Little Rock, Arkansas

Tri Valley Urology - Murrieta, Murrieta, California

Om Research LLC, San Diego, California

Associated Urological Specialists, Chicago Ridge, Illinois

Duly Health and Care, Lisle, Illinois

First Urology, Jeffersonville, Indiana

University of Kansas Medical Center (KUMC), Kansas City, Kansas

Johns Hopkins University, Baltimore, Maryland

Memorial Sloan Kettering Cancer Center - Sidney Kimmel Center for Prostate and Urologic Cancers, New York, New York

The Bronx Veterans Medical Research Foundation, Inc., The Bronx, New York

Duke Cancer Institute, Durham, North Carolina

Associate Urologist of North Carolina, Raleigh, North Carolina

Oregon Urology Institute, Springfield, Ohio

MidLantic Urology, Bala-Cynwyd, Pennsylvania

Keystone Urology Specialists, Lancaster, Pennsylvania

Carolina Urologic Research Center, Myrtle Beach, South Carolina

Lowcounty Urology Clinics, P.A., North Charleston, South Carolina

Urology Associates PC, Nashville, Tennessee

Baylor College of Medicine, Houston, Texas

Urology San Antonio, San Antonio, Texas

Australia

Epworth Freemasons-Victoria Parade, Richmond, Victoria

Italy

Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy

Istituto Europeo di Oncologia, Milan

Azienda Ospedaliero Universitaria Pisana - Ospedale Santa Chiara, Pisa

ASL Napoli 2 Nord - Ospedale Santa Maria delle Grazie, Pozzuoli

Spain

Centro Médico Teknon, Barcelona, Spain

Hospital Clínico San Carlos, Madrid, Spain

Hospital Universitario 12 de Oc, Madrid, Spain

Hospital Quirón Barcelona, Barcelona

MD Anderson Cancer Center - Madrid, Madrid

Hospital Universitario Ramón y Cajal, Madrid

Hospital Universitario Marqués de Valdecilla, Santander